INCR Intercure Ltd. - ordinary shares
NASDAQ · Pharmaceuticals · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Apr 30, 2026
$5.42
· of 52w range
· above low
· to high
$3.4052w low
$8.4552w high
P/E
-1.4
EPS
$-0.66
Revenue
$270M
your badges
52W Range
$3–$8
Analyst Rating
BUY
Price Target
·
P/E
-1.4
ROE
-9.0%
Net Profit Margin
-13.2%
Your badge strip is empty — pin a metric anywhere on this page.
INCR Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
Price
$5.42
P/E
-1.4
EPS
$-0.66
Revenue
$270M
ROE
-9.0%
52W Range
$3–$8
INCR Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
range
bars
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
Stock splits
| Ex-date | Split | Type |
|---|---|---|
| Aug. 24, 2026 | 1-for-5 | Reverse |
10-Year Performance Revenue, net income, margins and EPS trends
Revenue$270M2019-12-31 → 2025-12-31
EPS$-0.662019-12-31 → 2025-12-31
Free Cash Flow$13M2021-12-31 → 2025-12-31
Net margin-13.2%2021-12-31 → 2025-12-31
Valuation & Ratios
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | INCR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/E | -1.45Y avg ≈11.8 | ≈11.8 | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
| Metric | 5Y trend | INCR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Gross Margin | 12.3%5Y avg ≈27.2% | ≈27.2% | · | · | |
| Operating Margin | -10.1%5Y avg ≈-4.8% | ≈-4.8% | · | · | |
| EBITDA Margin | -10.1%5Y avg ≈-4.8% | ≈-4.8% | · | · | |
| Pretax Margin | -16.3%5Y avg ≈-10.1% | ≈-10.1% | · | · | |
| Net Profit Margin | -13.2%5Y avg ≈-9.1% | ≈-9.1% | · | · | |
| ROA | -4.9%5Y avg ≈-2.9% | ≈-2.9% | -24.3% | Top tier | |
| ROE | -9.0%5Y avg ≈-5.4% | ≈-5.4% | -43.8% | Top tier | |
| ROIC | -5.7%5Y avg ≈-3.4% | ≈-3.4% | · | · |
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | INCR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Quick Ratio | 0.25Y avg ≈0.5 | ≈0.5 | 0.5 | Low liquidity |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
No data for this ratio group yet
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
| Metric | 5Y trend | INCR | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Asset Turnover | 0.45Y avg ≈0.4 | ≈0.4 | · | · | |
| Inventory Turnover | 2.05Y avg ≈2.3 | ≈2.3 | · | · | |
| Revenue / Employee | ≈$948.1K | · | · | · |
value · ≈ 5Y avg · industry median · verdict relative to median
Earnings History EPS actual vs estimate, surprise %, beat rate, next earnings date
Avg Surprise
-18.2%
| Period | Report | EPS Actual | EPS Est | Surprise |
|---|---|---|---|---|
| June 30, 2023 | $0.53 | $0.41 | 28.7% | |
| March 31, 2023 | $0.03 | $0.20 | -87.7% | |
| Dec. 31, 2022 | $0.94 | $0.92 | 2.6% | |
| Sept. 30, 2022 | $0.80 | $1.27 | -37.3% | |
| March 31, 2022 | $0.19 | $0.18 | 2.6% |
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
Income Statement
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue | $270M | $239M | $356M | $389M | $220M | $65M | |
| Cost of Revenue | $230M | $203M | $247M | $230M | $124M | $35M | |
| Gross Profit | $33M | $30M | $105M | $155M | $91M | $32M | |
| R&D Expense | $390.0K | $414.0K | $388.0K | $632.0K | $1M | $2M | |
| SG&A Expense | $41M | $54M | $43M | $36M | $27M | $9M | |
| Operating Income | $-27M | $-67M | $-42M | $51M | $28M | $-38M | |
| Interest Income | $3M | $3M | $6M | $8M | $130.0K | $620.0K | |
| Pretax Income | $-44M | $-87M | $-61M | $44M | $19M | $-38M | |
| Income Tax | $-7M | $-15M | $2M | $93.0K | $11M | $-2M | |
| Net Income | $-36M | $-68M | $-62M | $45M | $5M | $-37M | |
| EPS (Basic) | $-0.66 | $-1.48 | $-1.36 | $0.99 | $0.12 | $-1.42 | |
| EPS (Diluted) | $-0.66 | $-1.48 | $-1.36 | $0.99 | $0.11 | $-1.42 | |
| Shares (Basic) | 53,743,140 | 45,869,177 | 45,572,689 | 45,352,601 | 38,492,600 | 25,396,312 | |
| EBITDA | $-27M | $-67M | $-42M | $51M | $28M | · |
Balance Sheet
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $45M | $18M | $95M | $192M | $193M | $38M | |
| Inventory | $108M | $120M | $105M | $140M | $62M | $19M | |
| Current Assets | · | $392M | $419M | $527M | $336M | $77M | |
| PP&E (Net) | $103M | $105M | $97M | $103M | $87M | $53M | |
| Goodwill | $219M | $225M | $221M | $284M | $268M | $190M | |
| Total Assets | $691M | $763M | $787M | $958M | $697M | $326M | |
| Current Liabilities | $214M | $227M | $226M | $313M | $194M | $30M | |
| Total Liabilities | $294M | $365M | $330M | $437M | $227M | $34M | |
| Retained Earnings | $-315M | $-278M | $-204M | $-142M | $-186M | $-191M | |
| Stockholders' Equity | $397M | $397M | $455M | $501M | $448M | $275M |
Cash Flow
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $17M | $-67M | $-54M | $51M | $30M | $8M | |
| CapEx | $4M | $4M | $3M | $20M | $14M | $21M | |
| Investing Cash Flow | $-2M | $18M | $5M | $-142M | $-65M | $-23M | |
| Financing Cash Flow | $-47M | $26M | $-83M | $120M | $198M | $25M | |
| Free Cash Flow | $13M | $-71M | $-56M | $32M | $11M | · |
Profitability
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Gross Margin | 12.3% | 12.7% | 29.6% | 39.9% | 41.5% | · | |
| Operating Margin | -10.1% | -28.1% | -11.7% | 13.0% | 12.8% | · | |
| Net Margin | -13.2% | -28.4% | -17.4% | 11.5% | 2.1% | · | |
| Pretax Margin | -16.3% | -36.6% | -17.2% | 11.3% | 8.5% | · | |
| EBITDA Margin | -10.1% | -28.1% | -11.7% | 13.0% | 12.8% | · | |
| ROA | -4.9% | -8.8% | -7.1% | 5.4% | 0.93% | · | |
| ROE | -9.0% | -15.9% | -13.0% | 9.4% | 1.3% | · | |
| ROIC | -5.7% | -14.1% | -9.5% | 10.1% | 2.5% | · |
Liquidity & Solvency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Current Ratio | · | 1.7 | 1.9 | 1.6 | 1.7 | · | |
| Quick Ratio | 0.2 | 0.1 | 0.4 | 0.6 | 1.0 | · |
Efficiency
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.4 | 0.3 | 0.4 | 0.5 | 0.4 | · | |
| Inventory Turnover | 2.0 | 1.8 | 2.0 | 2.5 | 3.0 | · |
Per Share
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| EPS (TTM) | $-0.66 | $-1.48 | $-1.36 | $0.99 | $0.11 | · |
Valuation (TTM)
| Metric | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Revenue TTM | $270M | $239M | $356M | $389M | $220M | · | |
| Net Income TTM | $-36M | $-68M | $-62M | $45M | $5M | · | |
| P/E | -1.4 | -1.1 | -0.9 | 3.3 | 58.9 | · | |
| Earnings Yield | -72.5% | -93.1% | -105.4% | 30.0% | 1.7% | · |
No quarterly filings for INCR
We don't have SEC filings for this ticker yet.
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Revenue | $270M | $239M | $356M | $389M | $220M |
| Gross Margin % | 12.3% | 12.7% | 29.6% | 39.9% | 41.5% |
| Operating Margin % | -10.1% | -28.1% | -11.7% | 13.0% | 12.8% |
| Net Income | $-36M | $-68M | $-62M | $45M | $5M |
| Diluted EPS | $-0.66 | $-1.48 | $-1.36 | $0.99 | $0.11 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Current Ratio | · | 1.7 | 1.9 | 1.6 | 1.7 |
| Quick Ratio | 0.2 | 0.1 | 0.4 | 0.6 | 1.0 |
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Free Cash Flow | $13M | $-71M | $-56M | $32M | $11M |
Institutional owners (13F) 17 filers · $749K total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
Holders
17
Value held
$749K
New positions
2
Exited positions
1
Institutional activity — Q2 2026 vs prior quarter
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 2 (+1 vs prior Q) | 1 (-3 vs prior Q) | 3 (+2 vs prior Q) | 4 (+1 vs prior Q) | +9K |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $325,125 | 212,500 | 43.44% | Shares |
| CITADEL ADVISORS LLC | $118,704 | 107,913 | 15.86% | Shares |
| MOORE CAPITAL MANAGEMENT, LP | $107,000 | 97,273 | 14.30% | Shares |
| RENAISSANCE TECHNOLOGIES LLC | $63,580 | 57,800 | 8.49% | Shares |
| Revisor Wealth Management LLC | $45,482 | 41,348 | 6.08% | Shares |
| BlackRock, Inc. | $22,550 | 20,500 | 3.01% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $22,392 | 20,357 | 2.99% | Shares |
| Atria Investments, Inc | $13,153 | 11,957 | 1.76% | Shares |
| Quent Capital, LLC | $11,353 | 10,321 | 1.52% | Shares |
| Quent Long Short Global Small Cap Fund, LP | $9,392 | 10,321 | 1.25% | Shares |
| MORGAN STANLEY | $4,490 | 4,082 | 0.60% | Shares |
| PenderFund Capital Management Ltd. | $2,175 | 1,977 | 0.29% | Shares |
| UBS Group AG | $1,466 | 1,333 | 0.20% | Shares |
| Financial Network Wealth Advisors LLC | $1,100 | 1,000 | 0.15% | Shares |
| NATIONAL BANK OF CANADA /FI/ | $517 | 508 | 0.07% | Shares |
| Virtu Financial LLC | $25 | 22,485 | 0.00% | Shares |
| ROYAL BANK OF CANADA | $0 | 196 | 0.00% | Shares |
Activists & 5%+ owners 1 position
Investors who filed SEC Schedule 13D — beneficial ownership above 5% with an intent to influence the issuer (activist stakes, board campaigns, M&A). Each row shows the most recent known state of that filer's position.
| Filer | Filed | Stake | Status | Purpose | Filing |
|---|---|---|---|---|---|
| Alexander Rabinovich, D.I.M Investments Ltd. | Dec. 9, 2025 | 29.40% | Initial filing | Passive investment | SEC |
Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.
Company insiders 1 insider · 1 officers · 0 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Amos Cohen | Chief Financial Officer | June 9, 2026 A | · | 0 | 0 | $0 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
INCR Analyst Consensus Bullish and bearish analyst opinions, 12-month price target, upside
rating · 7 analysts
BUY
2 28.6%
Strong Buy
4 57.1%
Buy
1 14.3%
Hold
0 0.0%
Sell
0 0.0%
Strong Sell
Peer comparison (GICS sub-industry) Key metrics vs sector peers
FY basis, prices as of each company's last fiscal year-end close.
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.
Source: SEC 20-F filed Apr 30, 2026